Eaton Corporation plc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Eaton Corporation plc trades at $428.84 (market cap $167.53B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B). The key difference: Eaton Corporation plc is far larger — about 73.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Eaton Corporation plc pays a 1.02% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ETN | SLS | |
|---|---|---|
Market Cap | $167.53B | $2.28B |
Volume | 1,729,194 | 3,128,960 |
Sector | Industrials | Health |
52-Week High | $459.96 | $15.46 |
52-Week Low | $315.82 | $1.39 |
Typical Hold Time | 31 Days | — |
Enterprise Value | $188.16B | $2.15B |
Dividend Yield | 1.02% | — |
Signals from Pluang's Aura AI — not financial advice
Eaton Corporation (ETN) trades at $431.33, down 3.09% today but maintains strong analyst support with 28 buy ratings and a $502.38 consensus price target. The company demonstrates consistent earnings beats in recent quarters and benefits from strategic acquisitions in data center and aerospace markets. Technical indicators show a bullish moving average trend with neutral oscillators, while fundamentals reveal solid profitability with 12.75% net income margin and 19.71% ROE.
ETN presents a compelling investment case driven by AI data center demand and grid modernization trends, though elevated valuation multiples (P/E 43.92) warrant monitoring. Key risks include execution of recent acquisitions and competitive pressures in the electrical equipment sector. The stock offers 16% upside to consensus targets with strong institutional conviction supporting long-term growth prospects.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →